DJIA 17,745.98 -5.41 -0.03%
NASDAQ 5,128.79 17.05 0.33%
S&P 500 2,108.63 0.06 0.00%
market minute promo

STEMCELLS, INC. (NASDAQ: STEM)

0.41 -0.01 (-3.38%)

Quote as of


company name or ticker

Recent Quotes

STEM $0.41 -3.38%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.41
Previous Close $0.42
Daily Range $0.40 - $0.43
52-Week Range $0.39 - $1.72
Market Cap $42.6M
P/E Ratio -0.81
Dividend (Yield) $0.00 (0.0%)
Volume 549,264
Average Daily Volume 1,625,991
Current FY EPS -$0.41

Sector

Healthcare

Industry

Drug Makers

STEMCELLS, INC. (STEM) Description

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders. Website: http://www.stemcellsinc.com/

News & Commentary Rss Feed

Cloning: A Stem Cell Revolution?

Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?

Neuralstem Wins Patent Infringement Case Vs. StemCell, Inc.; Moves Forward In Spinal Cord Injury

Health Care Sector Update for 07/20/2015: HRTX, ALNY, STEM

StemCells, Inc. Transplants First Patient in Phase II Clinical Trial for Dry Age-Related Macular Deg

StemCells, Inc. Transplants First Patient in Phase II Clinical Trial for Dry Age-Related Macular Degeneration

The Race To Treat Spinal Cord Injury: A Comparative Analysis

Will StemCells (STEM) Continue to Surge Higher? - Tale of the Tape

Health Care Sector Update for 06/04/2015: RGLS, NVGN, STEM

StemCells (STEM) Worth Watching: Stock Rises 10.7% - Tale of the Tape

Cantor: Time To Buy StemCells

Benzinga's Top Initiations

HC Wainwright: Buy StemCells, It's Worth $1/Share

See More STEM News...

STEM's Top Competitors

STEM $0.41 (-3.38%)
Current stock: STEM
AMGN $171.69 (0.13%)
Current stock: AMGN
GILD $117.90 (1.89%)
Current stock: GILD
BIIB $317.00 (1.17%)
Current stock: BIIB